Penumbra
PEN
$208.55
Share price
1.21%
Change (1 day)
-30.72%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.
Penumbra (PEN) - P/B ratio
P/B ratio as of May 2024 : 6.77
According to Penumbra's latest financial reports the company has a price-to-book ratio of 6.77.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Penumbra - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 8.23 | -2.64% |
| 2022-12-31 | 8.46 | -24.83% |
| 2021-12-31 | 11.3 | 12.94% |
| 2020-12-31 | 9.96 | -15.85% |
| 2019-12-31 | 11.8 | 18.85% |
| 2018-12-31 | 9.96 | 24.91% |
| 2017-12-31 | 7.98 | 5.3% |
| 2016-12-31 | 7.57 | 9.47% |
| 2015-12-31 | 6.92 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Merit Medical MMSI | 3.72 | -45.04% | 🇺🇸 USA |
 Inari Medical
NARI | 5.25 | -22.49% | 🇺🇸 USA |